Cardiac stem cell trials and the new world of cellular reprogramming: Time to move on.
作者信息
Rosengart Todd K, Patel Vivek, Sellke Frank W
机构信息
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex.
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex.
出版信息
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1642-1646. doi: 10.1016/j.jtcvs.2017.11.104. Epub 2017 Dec 26.
Abstract
摘要
相似文献
1
Cardiac stem cell trials and the new world of cellular reprogramming: Time to move on.心脏干细胞试验与细胞重编程的新世界：是时候向前迈进了。
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1642-1646. doi: 10.1016/j.jtcvs.2017.11.104. Epub 2017 Dec 26.
2
The Future of Cardiovascular Regenerative Medicine.心血管再生医学的未来
Circulation. 2016 Jun 21;133(25):2618-25. doi: 10.1161/CIRCULATIONAHA.115.019214.
3
Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells.再生医学/心脏细胞疗法：多能干细胞
Thorac Cardiovasc Surg. 2018 Jan;66(1):53-62. doi: 10.1055/s-0037-1608761. Epub 2017 Dec 7.
4
Vascular Regeneration With New Sources of Endothelial Cells.血管再生的新内皮细胞来源。
Circ Res. 2019 Jan 4;124(1):29-31. doi: 10.1161/CIRCRESAHA.118.314195.
5
microRNA and Cardiac Regeneration.微小RNA与心脏再生
Adv Exp Med Biol. 2015;887:119-41. doi: 10.1007/978-3-319-22380-3_7.
6
Cardiovascular Bio-Engineering: Current State of the Art.心血管生物工程：当前技术水平
J Cardiovasc Transl Res. 2017 Apr;10(2):180-193. doi: 10.1007/s12265-017-9740-6. Epub 2017 Mar 6.
7
Exosomes in Cardiovascular Diseases and Treatment: Experimental and Clinical Aspects.心血管疾病与治疗中的外泌体：实验与临床方面
J Cardiovasc Transl Res. 2019 Feb;12(1):1-2. doi: 10.1007/s12265-018-9860-7. Epub 2019 Jan 7.
8
Improving stem cell therapy in cardiovascular diseases: the potential role of microRNA.改善心血管疾病中的干细胞治疗：微小 RNA 的潜在作用。
Am J Physiol Heart Circ Physiol. 2016 Jul 1;311(1):H207-18. doi: 10.1152/ajpheart.00239.2016. Epub 2016 May 20.
9
Cardiac regeneration in 2017: Novel paradigms in the fight against heart failure.2017年的心脏再生：对抗心力衰竭的新范式。
Nat Rev Cardiol. 2018 Jan 16;15(2):73-74. doi: 10.1038/nrcardio.2017.218.
10
Cardiac stem cell therapy from bench to bedside.从实验台到临床的心脏干细胞治疗
Cell Transplant. 2007;16(9):875-8. doi: 10.3727/096368907783338262.
引用本文的文献
1
Partial Cell Fate Transitions to Promote Cardiac Regeneration.部分细胞命运转变以促进心脏再生。
Cells. 2024 Dec 4;13(23):2002. doi: 10.3390/cells13232002.
2
Clinical potential of angiogenic therapy and cellular reprogramming.血管生成疗法和细胞重编程的临床潜力。
JTCVS Open. 2021 Jun;6:108-115. doi: 10.1016/j.xjon.2020.12.023. Epub 2021 Mar 18.
3
Moving forward on the pathway of cell-based therapies in ischemic heart disease and heart failure - time for new recommendations?在缺血性心脏病和心力衰竭的细胞治疗道路上继续前行——是时候提出新建议了吗？
World J Stem Cells. 2019 Aug 26;11(8):445-451. doi: 10.4252/wjsc.v11.i8.445.
4
What's in a cardiomyocyte - And how do we make one through reprogramming?心肌细胞中有什么——我们如何通过重编程来制造一个心肌细胞？
Biochim Biophys Acta Mol Cell Res. 2020 Mar;1867(3):118464. doi: 10.1016/j.bbamcr.2019.03.011. Epub 2019 Mar 25.
本文引用的文献
1
Fibrogenic Potential of PW1/Peg3 Expressing Cardiac Stem Cells.表达 PW1/Peg3 的心脏干细胞的成纤维生成潜能。
J Am Coll Cardiol. 2017 Aug 8;70(6):728-741. doi: 10.1016/j.jacc.2017.06.010.
2
Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics.心肌梗死后的心脏再生和修复：新型治疗方法的转化机会。
Nat Rev Drug Discov. 2017 Oct;16(10):699-717. doi: 10.1038/nrd.2017.106. Epub 2017 Jul 21.
3
Cardiac Cell Therapies for the Treatment of Acute Myocardial Infarction: A Meta-Analysis from Mouse Studies.用于治疗急性心肌梗死的心脏细胞疗法：来自小鼠研究的荟萃分析
Cell Physiol Biochem. 2017;42(1):254-268. doi: 10.1159/000477324. Epub 2017 May 25.
4
Generation of induced cardiac progenitor cells via somatic reprogramming.通过体细胞重编程产生诱导性心脏祖细胞。
Oncotarget. 2017 Apr 25;8(17):29442-29457. doi: 10.18632/oncotarget.15272.
5
Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials.心肌病的细胞疗法：临床试验现状
Anal Cell Pathol (Amst). 2017;2017:9404057. doi: 10.1155/2017/9404057. Epub 2017 Jan 17.
6
Direct Cardiac Cellular Reprogramming for Cardiac Regeneration.用于心脏再生的直接心脏细胞重编程
Curr Treat Options Cardiovasc Med. 2016 Sep;18(9):58. doi: 10.1007/s11936-016-0480-8.
7
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.RENEW 试验：心肌内自体 CD34(+)细胞给药治疗难治性心绞痛的疗效和安全性。
JACC Cardiovasc Interv. 2016 Aug 8;9(15):1576-85. doi: 10.1016/j.jcin.2016.05.003.
8
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.《2016年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2016 Jan 26;133(4):e38-360. doi: 10.1161/CIR.0000000000000350. Epub 2015 Dec 16.
9
Direct cellular reprogramming for cardiac repair and regeneration.直接细胞重编程用于心脏修复和再生。
Eur J Heart Fail. 2016 Feb;18(2):145-56. doi: 10.1002/ejhf.446. Epub 2015 Dec 3.
10
Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotency.重编程的障碍与增强因素：提高诱导多能性效率和动力学的策略
Cell Regen. 2015 Nov 11;4:10. doi: 10.1186/s13619-015-0024-9. eCollection 2015.
Zotero 插件